“…Normalization of amygdala activity in patients following antidepressant treatment could reflect improvements in depression severity as well as, or alternatively, could be evidence of the effects of SSRI treatment on amygdala responses. The mechanism may be consistent with the density of serotonin receptors within the amygdala (Xu & Pandey, 2000) which are a target of action for SSRIs (Jiang, Chen, Smerin, Zhang, & Li, 2011). Short term administration of SSRIs in both healthy volunteers (Harmer, Mackay, Reid, Cowen, & Goodwin, 2006) and MDD patients (Godlewska, Norbury, Selvaraj, Cowen, & Harmer, 2012) had normalized amygdala responses to negative emotional stimuli, which preceded the clinical improvements (Godlewska et al, 2012), suggesting a therapeutic mechanism of SSRI treatment for MDD.…”